Charles River Laboratories International Inc - Company Profile
Powered by 
All the data and insights you need on Charles River Laboratories International Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Charles River Laboratories International Inc Strategy Report
- Understand Charles River Laboratories International Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Charles River Laboratories International Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20220282277A1 | Application | USE OF ION CONCENTRATIONS TO INCREASE THE PACKAGING EFFICIENCY OF RECOMBINANT ADENO-ASSOCIATED VIRUS | C12N15/86; C12N2500/14; C12N2500/16; C12N2710/10041; C12N5/16; C12N7/00 | September 08, 2022 |
| WO2022174082A1 | Application | HYBRID AMEBOCYTE LYSATE AND USES THEREOF | August 18, 2022 | |
| US20220257678A1 | Application | RECOMBINANTLY-MODIFIED ADENO-ASSOCIATED VIRUS (RAAV) HAVING IMPROVED PACKAGING EFFICIENCY | A61K35/761; C07K14/075; C12N15/86; C12N2710/10343; C12N2750/14143 | August 18, 2022 |
| US20220252582A1 | Application | CHO HOST CELL PROTEIN ASSAY | C07K16/00; C07K16/18; C07K2317/10; C07K2317/11; C07K2317/20; C07K2317/23; G01N33/541; G01N33/6803 | August 11, 2022 |
| EP4028584A1 | Application | VERFAHREN ZUR ANTIKÖRPERABSTIMMUNG GEGEN ZIELPROTEINE | C07K16/2896; C12N15/86; C12N2740/15041; C12N2740/16043; C12N2800/107; C40B30/04; G01N2333/726 | July 20, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer